Retatrutide (5mg / 10mg / 15mg / 30mg / 50mg) 4.88 out of 5 based on 16 customer ratings 49,99 159,99 Price range: 49,99 through 159,99 Certificate of Analysis Third-party purity report for Retatrutide (5mg / 10mg / 15mg / 30mg / 50mg) (PDF) for same-day dispatch --:--:-- Same-day EU dispatch Tracked & discreet Third-party tested COA on every batch Secure checkout Card Apple/Google Pay crypto Retatrutide Europe Triple Receptor Agonist Peptide Retatrutide Europe (LY3437943) is a synthetic acylated peptide and first-in-class triple agonist of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR), developed by Eli Lilly as a research candidate in metabolic disease pharmacology
This raises concerns about how cells might react over time
As a full opioid agonist, it helped stabilize individuals and reduce mortality, but strict regulations and stigma kept it out of reach for many
Frequently Asked Questions When you're deep in the weeds of peptide research, a few common questions always seem to pop up
B12 supplementation during GLP-1 therapy makes physiological sense